Bacterial flagellin is a dominant, stable innate immune activator in the gastrointestinal contents of mice and rats

References

• Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(8):e1002533. doi:10.1371/journal.pbio.1002533.
   PubMed Web of Science ®Google Scholar
• Gewirtz AT, Navas TA, Lyons S, Godowski PJ, Madara JL. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. Eur J Immunol. 2001;167(4):1882–10. doi:10.4049/jimmunol.167.4.1882.
   Google Scholar
• Raby AC, Le Bouder E, Colmont C, Davies J, Richards P, Coles B, George CH, Jones SA, Brennan P, Topley N, et al. Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering. Eur J Immunol. 2009;183(1):506–517. doi:10.4049/jimmunol.0802909.
   Google Scholar
• Zunt SL, Burton LV, Goldblatt LI, Dobbins EE, Srinivasan M. Soluble forms of toll-like receptor 4 are present in human saliva and modulate tumour necrosis factor-α secretion by macrophage-like cells. Clin Exp Immunol. 2009;156(2):285–293. doi:10.1111/j.1365-2249.2009.03854.x.
   PubMed Web of Science ®Google Scholar
• LeBouder E, Rey-Nores JE, Rushmere NK, Grigorov M, Lawn SD, Affolter M, Griffin GE, Ferrara P, Schiffrin EJ, Morgan BP, et al. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. Eur J Immunol. 2003;171(12):6680–6689. doi:10.4049/jimmunol.171.12.6680.
   Google Scholar
• Gewirtz AT, Simon PO Jr., Schmitt CK, Taylor LJ, Hagedorn CH, O’brien AD, Neish AS, Madara JL. Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response. J Clin Invest. 2001;107(1):99–109. doi:10.1172/JCI10501.
   PubMed Web of Science ®Google Scholar
• Lyons S, Wang L, Casanova JE, Sitaraman SV, Merlin D, Gewirtz AT. Salmonella typhimurium transcytoses flagellin via an SPI2-mediated vesicular transport pathway. J Cell Sci. 2004;117(24):5771–5780. doi:10.1242/jcs.01500.
   PubMed Web of Science ®Google Scholar
• Hoshi N, Schenten D, Nish SA, Walther Z, Gagliani N, Flavell RA, Reizis B, Shen Z, Fox JG, Iwasaki A, et al. MyD88 signalling in colonic mononuclear phagocytes drives colitis in IL-10-deficient mice. Nat Commun. 2012;3(1):1120. doi:10.1038/ncomms2113.
   PubMedGoogle Scholar
• Smith KD, Andersen-Nissen E, Hayashi F, Strobe K, Bergman MA, Barrett SL, Cookson BT, Aderem A. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat Immunol. 2003;4(12):1247–1253. doi:10.1038/ni1011.
   PubMed Web of Science ®Google Scholar
• Guo S, Al-Sadi R, Said HM, Ma TY. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am J Pathol. 2013;182(2):375–387. doi:10.1016/j.ajpath.2012.10.014.
   PubMed Web of Science ®Google Scholar
• Galloway SM, Raetz CR. A mutant of escherichia coli defective in the first step of endotoxin biosynthesis. J Biol Chem. 1990;265(11):6394–6402. doi:10.1016/S0021-9258(19)39339-1.
   PubMed Web of Science ®Google Scholar
• Murphy ST, Bellamy MC. The quest for the magic bullet: centoxin, drotrecogin alfa and lessons not learned. Trends Anaesth Crit. 2013;3(6):316–319. doi:10.1016/j.tacc.2013.05.004.
   Google Scholar
• Rice TW, Wheeler AP, Bernard GR, Vincent J-L, Angus DC, Aikawa N, Demeyer I, Sainati S, Amlot N, Cao C, et al. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med. 2010;38(8):1685–1694. doi:10.1097/CCM.0b013e3181e7c5c9.
   PubMed Web of Science ®Google Scholar
• Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP, Wittebole X, Dugernier T, Perrotin D, Tidswell M, et al. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. Jama. 2013;309(11):1154–1162. doi:10.1001/jama.2013.2194.
   PubMed Web of Science ®Google Scholar
• d’Hennezel E, Abubucker S, Murphy LO, Cullen TW, Lozupone C. Total lipopolysaccharide from the human gut microbiome silences toll-like receptor signaling. mSystems. 2017; 2(6). doi:10.1128/mSystems.00046-17.
   PubMed Web of Science ®Google Scholar
• Vatanen T, Kostic AD, d’Hennezel E, Siljander H, Franzosa EA, Yassour M, Kolde R, Vlamakis H, Arthur T, Hämäläinen A-M, et al. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell. 2016;165(4):842–853. doi:10.1016/j.cell.2016.04.007.
   PubMed Web of Science ®Google Scholar
• Lozupone C, Faust K, Raes J, Faith JJ, Frank DN, Zaneveld J, Gordon JI, Knight R. Identifying genomic and metabolic features that can underlie early successional and opportunistic lifestyles of human gut symbionts. Genome Res. 2012;22(10):1974–1984. doi:10.1101/gr.138198.112.
   PubMed Web of Science ®Google Scholar
• Alexander KL, Zhao Q, Reif M, Rosenberg AF, Mannon PJ, Duck LW, Elson CO. Human microbiota flagellins drive adaptive immune responses in crohn’s disease. Gastroenterology. 2021;161(2):522–35 e6. doi:10.1053/j.gastro.2021.03.064.
   PubMed Web of Science ®Google Scholar
• Lodes MJ, Cong Y, Elson CO, Mohamath R, Landers CJ, Targan SR, Fort M, Hershberg RM. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest. 2004;113(9):1296–1306. doi:10.1172/JCI200420295.
   PubMed Web of Science ®Google Scholar
• Gewirtz AT, Vijay-Kumar M, Brant SR, Duerr RH, Nicolae DL, Cho JH. Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn’s disease. Am J Physiol Gastrointest Liver Physiol. 2006;290(6):G1157–63. doi:10.1152/ajpgi.00544.2005.
   PubMed Web of Science ®Google Scholar
• Scheithauer TPM, Herrema H, Yu H, Bakker GJ, Winkelmeijer M, Soukhatcheva G, Dai D, Ma C, Havik SR, Balvers M, et al. Gut-derived bacterial flagellin induces beta-cell inflammation and dysfunction. Gut Microbes. 2022;14(1):2111951. doi:10.1080/19490976.2022.2111951.
   PubMed Web of Science ®Google Scholar
• Zhang B, Chassaing B, Shi Z, Uchiyama R, Zhang Z, Denning TL, Crawford SE, Pruijssers AJ, Iskarpatyoti JA, Estes MK, et al. Prevention and cure of rotavirus infection via TLR5/NLRC4–mediated production of IL-22 and IL-18. Science. 2014;346(6211):861–865. doi:10.1126/science.1256999.
   PubMed Web of Science ®Google Scholar
• Jones RM, Sloane VM, Wu H, Luo L, Kumar A, Kumar MV, Gewirtz AT, Neish AS. Flagellin administration protects gut mucosal tissue from irradiation-induced apoptosis via MKP-7 activity. Gut. 2011;60(5):648–657. doi:10.1136/gut.2010.223891.
   PubMed Web of Science ®Google Scholar
• Vijay-Kumar M, Aitken JD, Sanders CJ, Frias A, Sloane VM, Xu J, Neish AS, Rojas M, Gewirtz AT. Flagellin treatment protects against chemicals, bacteria, viruses, and radiation. Eur J Immunol. 2008;180(12):8280–8285. doi:10.4049/jimmunol.180.12.8280.
   Google Scholar
• Vijay-Kumar M, Wu H, Jones R, Grant G, Babbin B, King TP, Kelly D, Gewirtz AT, Neish AS. Flagellin suppresses epithelial apoptosis and limits disease during enteric infection. Am J Pathol. 2006;169(5):1686–1700. doi:10.2353/ajpath.2006.060345.
   PubMed Web of Science ®Google Scholar
• Burdelya LG, Krivokrysenko VI, Tallant TC, Strom E, Gleiberman AS, Gupta D, Kurnasov OV, Fort FL, Osterman AL, Didonato JA, Feinstein, E, Gudkov, AV, et al. An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science. 2008;320(5873):226–230. doi:10.1126/science.1154986.
   PubMed Web of Science ®Google Scholar